Opko Health (OPK) | Stock Overview & Key Data
Opko Health Performance Comparison
Stock Range
Today's Range
Low: $1.36
High: $1.40
on August 21, 2025
52 Week Range
Low: $1.11
High: $2.04
on August 1, 2025
on March 5, 2025
All-Time High: $19.20 on June 1, 2015
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.1B
EPS
-0.26
P/E Ratio (TTM)
-17.13
Forward P/E
-4.72
P/B Ratio
0.82
PEG Ratio
-4.72
Div. Yield
N/A
ROE
-13.16%
Beta
1.189
Debt to Equity
30.51
Financial Highlights
Profitability
Gross Margin
31.50%
Operating Margin
-38.25%
Profit Margin
-26.68%
Returns and Earnings
Return on Assets (TTM)
-8.46%
Return on Equity (TTM)
-13.16%
EBITDA
$39.9M
Net Income (TTM)
$-177.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.99
Quarterly Revenue Growth (YoY)
-13.90%
Quarterly Earnings Growth (YoY)
-13.93%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Opko Health OPK | 1.09B Small-cap | 2.22% | -1.43% | 6.15% | -17.86% | -4.83% | -14.29% | -40.26% | -58.68% |
| Thermo Fisher TMO | 184.10B Large-cap | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% | -20.19% | -14.18% | 13.97% |
| Danaher DHR | 151.04B Large-cap | -3.01% | 8.42% | 9.15% | -3.01% | -11.27% | -24.34% | -17.95% | 11.85% |
| Twist Bioscience TWST | 1.69B Small-cap | -8.22% | -23.87% | -7.02% | -35.92% | -41.58% | -39.37% | -38.58% | -61.61% |
| Neogen NEOG | 1.22B Small-cap | 1.82% | 17.15% | -9.97% | -44.22% | -53.10% | -66.63% | -73.62% | -85.24% |
| Grail GRAL | 1.13B Small-cap | 3.01% | -3.49% | -11.51% | -18.61% | 84.99% | 115.12% | 126.74% | 126.74% |
Ownership & Short Interest
Insider Ownership
46.77%
Institutional Ownership
26.37%
Shares Short
33M
Short Ratio
13.42
Short % of Shares Outstanding
7.03%
Average 10-Day Volume
3M
Average 90-Day Volume
3M
Opko Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Opko Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is OPK's 52-week high and low?
- In the last 52 weeks, Opko Health reached a high of $2.04 (on March 5, 2025) and a low of $1.11 (on August 1, 2025).
- What is the market cap and P/E ratio for OPK?
- Curious about Opko Health's size and valuation? Its market capitalization stands at 1.09B. When it comes to valuation, the P/E ratio (trailing twelve months) is -17.13, and the forward P/E (looking ahead) is -4.72.
- Does OPK pay dividends? If so, what's the yield?
- As for dividends, Opko Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Opko Health's main competitors or similar companies to consider before investing?
When looking at Opko Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -20.19% -14.18% Danaher
DHR151.04B Healthcare Diagnostics & Research -24.34% -17.95% Twist Bioscience
TWST1.69B Healthcare Diagnostics & Research -39.37% -38.58% Neogen
NEOG1.22B Healthcare Diagnostics & Research -66.63% -73.62% Grail
GRAL1.13B Healthcare Diagnostics & Research 115.12% 126.74% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Opko Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Opko Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -13.16%, the Debt to Equity ratio from the most recent quarter is 30.51, and its Gross Profit Margin stands at 31.50%.
- What is the recent revenue and earnings growth for OPK?
- Looking at Opko Health's growth, its revenue over the trailing twelve months (TTM) was $664M. Compared to the same quarter last year (YoY), quarterly revenue grew by -13.90%, and quarterly earnings saw a YoY growth of -13.93%.
- How much of OPK stock is held by insiders and institutions?
- Wondering who owns Opko Health stock? Company insiders (like executives and directors) hold about 46.77% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 26.37%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.